Pharmafile Logo

IPF World Week

- PMLiVE

UK’s NICE recommends Roche’s Evrysdi

The first oral therapy for the leading genetic cause of death among babies and young children will be available to 1,500 people in England after Roche signed a price-cutting deal

Graphic showing person with megaphone and two speech bubbles

Opening up about patient engagement

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Cuttsy + Cuttsy

- PMLiVE

Delivering outcomes-led solutions with connected capabilities

Founded in 2007, Lucid Group has grown from a small UK-based medical education agency to a global healthcare consultancy and employs over 400 people with several offices in the UK...

Lucid Group Communications Limited

- PMLiVE

Roche and Novartis part ways with share purchase

Novartis is to sell its one-third stake in Roche for more than $20bn, paving the way for potential acquisitions

Pioneers of the First Virtual Hospital

Raphael Rakowski, Executive Chairman of Medically Home, explores the concepts of “virtual hospitals” and “hospital-at-home,” including current barriers, benefits, and the many considerations for making it a reality.

Impetus Digital

- PMLiVE

New data shows Roche’s Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses

Enspryng is the first and only NMOSD treatment administered subcutaneously every four weeks

Graphic showing light bulbs with numbers on

Committing time to making meaningful connections – top 5 tips

Read the second blog of the series looking at key barriers to effective patient engagement in pharma

Cuttsy + Cuttsy

Two hands shaking symbolising partnership

Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly

In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly

Cuttsy + Cuttsy

Webcast:

Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy

Research Partnership

Steven Cohen at BOLDSCIENCE

BOLDSCIENCE welcomes Steven Cohen to its leadership team to expand its strategic communication consulting services into regulatory approvals

Medical communications agency BOLDSCIENCE has hired industry veteran Steven Cohen to lead a new division that will help pharmaceutical and biotech clients navigate the most critical challenges they face throughout...

BOLDSCIENCE

Roche Basel Switzerland

New data for Tecentriq in early-stage lung cancer

Roche’s PD-L1 blocker reduced the risk of disease recurrence and death for patients with stage 2-3a non-small cell lung cancer following surgery

Roche Basel Switzerland

Roche expands infectious disease test portfolio

PCR test specialist TIB Molbiol will join Roche to bolster its molecular diagnostics solutions for infectious diseases

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links